Egyptian International Pharmaceutical Industries Dividends and Buybacks
Dividend criteria checks 2/6
Egyptian International Pharmaceutical Industries is a dividend paying company with a current yield of 2.12% that is well covered by earnings.
Key information
2.1%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 2.1% |
| Future Dividend Yield | 2.1% |
| Dividend Growth | -5.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ج.م1.000 |
| Payout ratio | 13% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: PHAR has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: PHAR has only been paying a dividend for 8 years, and since then payments have fallen.
Dividend Yield vs Market
| Egyptian International Pharmaceutical Industries Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PHAR) | 2.1% |
| Market Bottom 25% (EG) | 2.0% |
| Market Top 25% (EG) | 7.4% |
| Industry Average (Pharmaceuticals) | 3.2% |
| Analyst forecast (PHAR) (up to 3 years) | 2.1% |
Notable Dividend: PHAR's dividend (2.12%) is higher than the bottom 25% of dividend payers in the EG market (2.02%).
High Dividend: PHAR's dividend (2.12%) is low compared to the top 25% of dividend payers in the EG market (7.35%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (12.8%), PHAR's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: PHAR is paying a dividend but the company has no free cash flows.